查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1547765

全球經皮皮膚貼片市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Transdermal Skin Patches Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

全球經皮皮膚貼片市場需求預計將從 2023 年的 84.1 億美元達到 2032 年近 133 億美元的市場規模，2024-2032 年研究期間複合年成長率為 5.23%。

經皮貼片是經皮技術的一種。它是一種貼在皮膚上的含藥貼劑，可提供特定劑量的藥物。這些貼片使用擴散技術透過皮膚提供藥物劑量，隨後在很長一段時間內釋放到血液中。這些貼片可有效用於治療荷爾蒙和心臟疾病。這些貼片也用於治療偏頭痛、帕金森氏症、阿茲海默症、中風、愛滋病毒、骨質疏鬆症、皮膚病相關問題和不寧腿症候群治療。

市場動態

促進市場成長的主要因素是經皮藥物相對於傳統藥物（胃腸道毒性藥物）的優勢越來越大，導致噁心和嘔吐。由於它們本質上是非侵入性的，因此減少了靜脈或腸胃外治療造成的不便。主要優點是貼片通常透過覆蓋藥物儲存的多孔膜或透過體溫熔化沉積在黏合劑中的薄層藥物，將藥物控制釋放到患者體內。此外，增加藥物開發的資金和投資也促進了市場的成長。然而，皮膚無法吸收一系列活性物質預計將阻礙市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球經皮皮膚貼片市場的每個細分市場進行了包容性評估。經皮皮膚貼片產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

經皮皮膚貼片市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

依產品類型

  • 水庫
  • 藥物黏合劑（單層、多層）
  • 微型針
  • 矩陣
  • 其他（蒸氣等）

按申請

  • 疼痛管理
  • 荷爾蒙失調
  • 減少吸菸和戒菸援助
  • 神經系統疾病
  • 心血管疾病
  • 其他（暈車、膀胱過動症等）

按銷售類型

  • 處方
  • 場外交易 (OTC)

按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路藥局

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的經皮皮膚貼片市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。經皮皮膚貼片市場的主要參與者包括Hisamitsu Pharmaceutical Co. Inc.、Viatris Inc.、Nitto Denko Corporation、Novartis AG、Luye Pharma Group、Teikoku Pharma、Samyang Holdings Corporation、Gedeon Richter PLC、AdhexPharma、Sparsha Pharma International Pvt Ltd本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：經皮貼片 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 市場吸引力分析：按產品類型
    • 市場吸引力分析：依應用分類
    • 按銷售類型分類的市場吸引力分析
    • 按配銷通路分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球經皮皮膚貼片市場分析：依產品類型

  • 概述：按產品類型
  • 歷史和預測數據
  • 分析：依產品類型
  • 水庫
  • 藥物黏合劑（單層、多層）
  • 微型針
  • 矩陣
  • 其他（蒸氣等）

第 6 章：全球經皮皮膚貼片市場分析：依應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 疼痛管理
  • 荷爾蒙失調
  • 減少吸菸和戒菸援助
  • 神經系統疾病
  • 心血管疾病
  • 其他（暈車、膀胱過動症等）

第 7 章：全球經皮皮膚貼片市場分析：依銷售類型

  • 按銷售類型概述
  • 歷史和預測數據
  • 按銷售類型分析
  • 處方
  • 場外交易 (OTC)

第 8 章：全球經皮皮膚貼片市場分析：按分銷管道

  • 配銷通路概覽
  • 歷史和預測數據
  • 按配銷通路分析
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 9 章：全球經皮皮膚貼片市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：經皮貼片公司的競爭格局

  • 經皮皮膚貼片市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Hisamitsu Pharmaceutical Co. Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Viatris Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Nitto Denko Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Novartis AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Luye Pharma Group
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Teikoku Pharma
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Samyang Holdings Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Gedeon Richter PLC
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • AdhexPharma
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sparsha Pharma International Pvt Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11213473

The global demand for Transdermal Skin Patches Market is presumed to reach the market size of nearly USD 13.3 Billion by 2032 from USD 8.41 Billion in 2023 with a CAGR of 5.23% under the study period 2024-2032.

A transdermal patch is a type of transdermal technology. It is a medicated adhesive patch placed on the skin to deliver a specific dose of medication. These patches provide medication dose though the skin using the diffusion technique, which later gets released in the bloodstream over a long period. These patches are effectively used for the treatment of hormonal and cardiac disorders. These patches are also used to treat migraine, Parkinsons disease, Alzheimer's, strokes, HIV, osteoporosis, dermatology-related issues, and restless leg syndrome treatments.

MARKET DYNAMICS

The primary factor contributing to the growth of the market is the increasing advantages of transdermal medicine over the conventional way of medications (medications for gastrointestinal toxicity), resulting in nausea and vomiting. As they are non-invasive in nature, they reduce the inconvenience caused due to intravenous or parenteral therapies. The main advantage is that the patch provides a controlled release of the medication into the patient, generally through either a porous membrane covering the storage of medication or through body heat melting thin layers of medication deposited in the adhesive. Additionally, increasing funding and investments for drug development boosts the market growth. However, the skin's inability to absorb a range of active substances is expected to impede the market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Transdermal Skin Patches. The growth and trends of Transdermal Skin Patches industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Transdermal Skin Patches market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Reservoir
  • Drug-in-Adhesive (Single Layer, Multilayer)
  • Microneedle
  • Matrix
  • Others (Vapor, etc.)

By Application

  • Pain Management
  • Hormonal Disorders
  • Smoking Reduction and Cessation Aid
  • Neurological Disorders
  • Cardiovascular Disorders
  • Others (Motion Sickness, Overactive Bladder, etc.)

By Sales Type

  • Prescription
  • Over-the-Counter (OTC)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Transdermal Skin Patches market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Transdermal Skin Patches market include Hisamitsu Pharmaceutical Co. Inc., Viatris Inc., Nitto Denko Corporation, Novartis AG, Luye Pharma Group, Teikoku Pharma, Samyang Holdings Corporation, Gedeon Richter PLC, AdhexPharma, Sparsha Pharma International Pvt Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. TRANSDERMAL SKIN PATCHES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Sales Type
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product Type
  • 5.4. Reservoir Historic and Forecast Sales By Regions
  • 5.5. Drug-in-Adhesive (Single Layer, Multilayer) Historic and Forecast Sales By Regions
  • 5.6. Microneedle Historic and Forecast Sales By Regions
  • 5.7. Matrix Historic and Forecast Sales By Regions
  • 5.8. Others (Vapor, etc.) Historic and Forecast Sales By Regions

6. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Application
  • 6.4. Pain Management Historic and Forecast Sales By Regions
  • 6.5. Hormonal Disorders Historic and Forecast Sales By Regions
  • 6.6. Smoking Reduction and Cessation Aid Historic and Forecast Sales By Regions
  • 6.7. Neurological Disorders Historic and Forecast Sales By Regions
  • 6.8. Cardiovascular Disorders Historic and Forecast Sales By Regions
  • 6.9. Others (Motion Sickness, Overactive Bladder, etc.) Historic and Forecast Sales By Regions

7. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY SALES TYPE

  • 7.1. Overview By Sales Type
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Sales Type
  • 7.4. Prescription Historic and Forecast Sales By Regions
  • 7.5. Over-the-Counter (OTC) Historic and Forecast Sales By Regions

8. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Distribution Channel
  • 8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Retail Pharmacies Historic and Forecast Sales By Regions
  • 8.6. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE TRANSDERMAL SKIN PATCHES COMPANIES

  • 10.1. Transdermal Skin Patches Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF TRANSDERMAL SKIN PATCHES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Hisamitsu Pharmaceutical Co. Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Viatris Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Nitto Denko Corporation
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Novartis AG
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Luye Pharma Group
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Teikoku Pharma
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Samyang Holdings Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Gedeon Richter PLC
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. AdhexPharma
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Sparsha Pharma International Pvt Ltd
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Reservoir Market Sales By Geography (USD MN)
  • Drug-in-Adhesive (Single Layer, Multilayer) Market Sales By Geography (USD MN)
  • Microneedle Market Sales By Geography (USD MN)
  • Matrix Market Sales By Geography (USD MN)
  • Others (Vapor, etc.) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Hormonal Disorders Market Sales By Geography (USD MN)
  • Smoking Reduction and Cessation Aid Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Others (Motion Sickness, Overactive Bladder, etc.) Market Sales By Geography (USD MN)
  • Analysis By Sales Type (USD MN)
  • Prescription Market Sales By Geography (USD MN)
  • Over-the-Counter (OTC) Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Transdermal Skin Patches Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Transdermal Skin Patches Report
  • Market Research Process
  • Market Research Methodology
  • Global Transdermal Skin Patches Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Sales Type
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Reservoir Market Sales By Geography (USD MN)
  • Drug-in-Adhesive (Single Layer, Multilayer) Market Sales By Geography (USD MN)
  • Microneedle Market Sales By Geography (USD MN)
  • Matrix Market Sales By Geography (USD MN)
  • Others (Vapor, etc.) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Hormonal Disorders Market Sales By Geography (USD MN)
  • Smoking Reduction and Cessation Aid Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Others (Motion Sickness, Overactive Bladder, etc.) Market Sales By Geography (USD MN)
  • Global Market Analysis By Sales Type (USD MN)
  • Prescription Market Sales By Geography (USD MN)
  • Over-the-Counter (OTC) Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.